There is Money in Healthcare Long after the Pandemic

Pandemics comes and go, but there is still money to be made in healthcare.  Once the dust dies down with global vaccination efforts, pharmaceutical companies will be serving a growing customer demographic that is essentially a captive customer base – ageing populations in developed countries.  Due to advances in healthcare, people are living longer, and surviving critical illnesses for longer periods of time.  Medical inflation is well into double digits in wealthy countries, and even with measures to manage medical cost, demand will push supply for newer drugs and treatments.